Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 464 entries
View as:

Spectral Domain OCT Imaging in Patients With Optic Nerve Head Drusen (Tuebingen SD-OCT IN OPTIC NERVE HEAD DRUSEN STUDY)

Phase: N/A Priority: Normal
NCT ID: NCT02793206 Org: User:
Start: 08/01/11 End: 05/01/17 Due: 05/01/18

Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT06368375 Org: User:
Start: 01/01/23 End: 06/30/23 Due: 06/30/24

#Stayhealthy - Monitoring and Maintenance of Mental Health Under Conditions of Social Isolation During the Corona Crisis

Phase: N/A Priority: Normal
NCT ID: NCT04871386 Org: User:
Start: 04/15/20 End: 05/18/20 Due: 05/18/21

A Counter Measure for the Effects of Immune and Microbiome Changes in Environments With Limited ANtigen Diversity (ICELAND-TWO)

Phase: N/A Priority: Normal
NCT ID: NCT03746145 Org: User:
Start: 11/15/18 End: 12/31/24 Due: 12/31/25

Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables

Phase: N/A Priority: Normal
NCT ID: NCT02388672 Org: User:
Start: 03/31/15 End: 07/31/15 Due: 07/31/16

Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02642458 Org: User:
Start: 03/31/16 End: 07/31/20 Due: 07/31/21

Thrombolysis in stRoke With Unknown onSet Based on noncontrasT CT

Phase: N/A Priority: Normal
NCT ID: NCT03634748 Org: User:
Start: 09/01/17 End: 12/31/18 Due: 12/31/19

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4

Phase: N/A Priority: Normal
NCT ID: NCT03206190 Org: User:
Start: 07/01/18 End: 12/31/31 Due: 12/31/32

Fingerprint Characterization of Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT02372162 Org: User:
Start: 07/31/15 End: 06/01/19 Due: 06/01/20

Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias

Phase: N/A Priority: Normal
NCT ID: NCT02874911 Org: User:
Start: 09/30/12 End: 03/31/16 Due: 03/31/17

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

Phase: N/A Priority: Normal
NCT ID: NCT06291311 Org: User:
Start: 12/27/23 End: 12/31/25 Due: 12/31/26

Influence of tDCS on the Brain Activation Measured During the Decision Not to Smoke in High-risk Situations

Phase: N/A Priority: Normal
NCT ID: NCT05875194 Org: User:
Start: 10/15/22 End: 12/15/23 Due: 12/15/24

Specific PoC Testing of Coagulation in Patients Treated With DOAC 1

Phase: N/A Priority: Normal
NCT ID: NCT02825394 Org: User:
Start: 10/13/16 End: 07/31/21 Due: 07/31/22

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05914961 Org: User:
Start: 06/01/24 End: 04/30/35 Due: 04/30/36

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition

Phase: N/A Priority: Normal
NCT ID: NCT05937295 Org: User:
Start: 09/26/23 End: 01/31/27 Due: 01/31/28

Validation of the GATE Software

Phase: N/A Priority: Normal
NCT ID: NCT01265628 Org: User:
Start: 11/30/10 End: - Due: -

Work Physiological-Biomechanical Analysis of a Passive Exoskeleton to Support Occupational Lifting and Flexing Processes

Phase: N/A Priority: Normal
NCT ID: NCT03725982 Org: User:
Start: 01/18/19 End: 05/22/19 Due: 05/22/20

Comparison of Conventional With Sonography Assisted Breast Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02840864 Org: User:
Start: 07/31/15 End: 07/31/18 Due: 07/31/19

Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex

Phase: N/A Priority: Normal
NCT ID: NCT02920840 Org: User:
Start: 09/30/16 End: 04/30/17 Due: 04/30/18

Effect of High Caloric Diet on Brain Insulin Sensitivity and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT03590561 Org: User:
Start: 06/13/18 End: 03/10/20 Due: 03/10/21

Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Program

Phase: N/A Priority: Normal
NCT ID: NCT04760522 Org: User:
Start: 06/01/21 End: 07/31/27 Due: 07/31/28

Personalized Multi-peptide Vaccination in CLL Patients

Phase: N/A Priority: Normal
NCT ID: NCT04688385 Org: User:
Start: 12/23/20 End: 10/17/24 Due: 10/17/25

Benefits of a Cognitive Behavioral Therapy Intervention for Smoking Cessation Supported by Virtual Reality Smoking Cue Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03707106 Org: User:
Start: 01/31/17 End: 07/02/21 Due: 07/02/22

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Phase: N/A Priority: Normal
NCT ID: NCT00204542 Org: User:
Start: 06/30/05 End: 12/31/10 Due: 12/31/11

Goal-directed and Cue-dependent Behavior in Severe Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04187066 Org: User:
Start: 08/01/19 End: 12/01/24 Due: 12/01/25